Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease.
about
Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applicationsRegulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acidImmune therapy in inflammatory bowel disease and models of colitis.Noninvasive Longitudinal Study of a Magnetic Resonance Imaging Biomarker for the Quantification of Colon Inflammation in a Mouse Model of Colitis.Deficiency in expression of the signaling protein Sin/Efs leads to T-lymphocyte activation and mucosal inflammation.Adaptation of bacteria to the intestinal niche: probiotics and gut disorder.Ulcerative typhlocolitis associated with Helicobacter mastomyrinus in telomerase-deficient miceGene transfer approaches for the treatment of inflammatory bowel disease.Maternal microchimerism in pediatric inflammatory bowel disease.Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning.Pharmacological Evaluation of the SCID T Cell Transfer Model of Colitis: As a Model of Crohn's Disease.Acute dextran sulfate sodium (DSS)-induced colitis promotes gut microbial dysbiosis in mice.Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's diseaseNovel drug delivery strategies for the treatment of inflammatory bowel disease.Ultrasound imaging of splenomegaly as a proxy to monitor colon tumor development in Apc(min716/+) mice.Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract.Animal models of inflammatory bowel disease: a review.Immune deficiency vs. immune excess in inflammatory bowel diseases-STAT3 as a rheo-STAT of intestinal homeostasis.Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases.Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development.The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases.Expression of catalytic proteasome subunits in the gut of patients with Crohn's disease.Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP.Illuminating the role of type I IFNs in colitis.Effects of a combination of thyme and oregano essential oils on TNBS-induced colitis in mice.In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy.Comparison of multiple enzyme activatable near-infrared fluorescent molecular probes for detection and quantification of inflammation in murine colitis models.T-bet as a possible therapeutic target in autoimmune disease.Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling.Exacerbation of ulcerative colitis after rituximab salvage therapy.Therapeutic effect of the immunomodulator glatiramer acetate on trinitrobenzene sulfonic acid-induced experimental colitis.Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis.Piroxicam treatment of IL-10-deficient mice enhances colonic epithelial apoptosis and mucosal exposure to intestinal bacteria.In vivo imaging of reactive oxygen and nitrogen species in murine colitis.Oral administration of dextran sodium sulphate induces a caecum-localized colitis in rabbits.Precancerous ACF induction affects their regional distribution forsaking oxidative stress implication in 1,2-dimethylhydrazine-induced colon carcinogenesis model.Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD).Monitoring of Chemically Induced Colitis.Protective and reparative effects of peptides from soybean β-conglycinin on mice intestinal mucosa injury.
P2860
Q28282507-EE3DA8E2-4DFB-438B-BE3E-4095EB33156CQ30499069-74EA1D12-27E5-46B7-B218-75EAADFDC466Q30774968-AD0FFFE5-8400-42D5-AC77-0C9E564FF45BQ31083125-8F695D77-7C63-4960-9243-A503EA00ED14Q34230864-468FF9B8-5192-4DAD-903D-543EED194B06Q34268168-9ECE45FA-4066-48A2-875C-C3B1BBD91AD5Q34836569-B0817042-1E05-4B09-A4B5-DB6529AFA45AQ35122162-7719325F-DC69-4E8B-890B-AA3D2C4F70E5Q35194858-43C38DFD-C94C-45E7-A4DC-9867E4244615Q35199488-0E9B6A6D-C003-49EA-B80C-72AE486EA7E6Q35895310-30DA808B-D3B1-461B-8FBB-6452E2E75A85Q35998545-753871F9-80FE-4807-8DC5-B8B91EC2CE0BQ36139885-5CB0D2A3-E645-4AB3-8D01-CFEF4837F268Q36316765-CE1FEE33-FACB-405B-B4F7-17D2BC3DB56FQ37321017-8D4BA3FF-4F85-4088-B344-7AF11D6DEDD0Q37769184-762682A8-9ADF-4A16-85D3-A6889952A3A7Q38218335-9A6BCD1C-1A15-4428-97D9-F84582259D28Q38558749-796EE289-12F0-4248-B3F5-C26ECE9C6D07Q38656159-369D5048-ACB4-43DC-894D-0D5F1AB09B17Q38659150-22DFE05E-F5E6-4C38-895D-5907364F8088Q38685181-63B08FE2-0B1E-4690-B18A-6821BA270BA8Q38881849-02596DB4-EB45-4447-9D7B-1F528F7EC402Q41810371-EE10219E-54D3-486C-A5E3-ECAA8F1D7E91Q41884883-A994C0A1-62A0-423F-B2EA-014AF624CC3AQ41901994-D1122477-3A0E-4FD6-891F-6C2DBB093C46Q41932893-F44DE943-E286-46C8-ABF2-BAE4CC5A180CQ42003082-1D6029DF-1B10-4B26-BEEB-3E143BD88D10Q43203577-113F2121-4848-4498-BED5-E57F11ECE46EQ44586207-A31B8872-660C-4B55-8579-38FC25885B98Q45119523-CC2CF205-1124-4831-B727-4882F5358AF0Q45226801-BD321A6A-1108-4CD5-8C12-1C4F47A0F457Q45242443-46227266-F4B1-4889-AA5E-355508A42FDBQ45282194-FC3EE665-3750-45EA-97CF-3C0ED590E453Q46819055-BE4D753F-15C8-4609-A4CB-257A9C8FDC97Q46872030-C4BB8219-2784-4524-B647-ABA5FA97A576Q48221693-2B2EAB2D-BF64-4070-8A32-0805F6D09845Q48363123-31608B5B-DE55-4D6F-967D-396111184095Q52710064-0E2841B2-7E63-45C0-8C80-4F8375393C30Q52930694-3E20089D-5306-4482-B407-AD9EF33FC77BQ53672135-0D1542FA-B32A-4971-BCF8-DB260A18CE90
P2860
Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Animal models of intestinal in ...... of inflammatory bowel disease.
@ast
Animal models of intestinal in ...... of inflammatory bowel disease.
@en
Animal models of intestinal in ...... of inflammatory bowel disease.
@nl
type
label
Animal models of intestinal in ...... of inflammatory bowel disease.
@ast
Animal models of intestinal in ...... of inflammatory bowel disease.
@en
Animal models of intestinal in ...... of inflammatory bowel disease.
@nl
prefLabel
Animal models of intestinal in ...... of inflammatory bowel disease.
@ast
Animal models of intestinal in ...... of inflammatory bowel disease.
@en
Animal models of intestinal in ...... of inflammatory bowel disease.
@nl
P356
P1476
Animal models of intestinal in ...... of inflammatory bowel disease.
@en
P2093
P2888
P304
P356
10.1007/S003840000227
P577
2000-06-01T00:00:00Z
P5875
P6179
1052487666